3 reports

  • CAR-T
  • 8.4.2. CAR-T DESIGN

INTRODUCTION Amidst the current initiatives to develop more targeted anti-cancer therapies, chimeric antigen receptor T-cell (CAR-T) therapy has emerged as a potent and viable therapeutic intervention to eradicate tumor cells, with minimal side effects. It is based on the principle of harnessing the innate potential of...

  • Automotive
  • Clinical Trial
  • Motor Vehicle
  • Therapy
  • Juno Therapeutics Inc.
  • THERAPIES

CAR-T IS ONE AMONGST A NUMBER OF ADVANCED NOVEL PERSONALIZED IMMUNOTHERAPIES.

  • Automotive
  • Lymphoma
  • Monoclonal Antibody
  • Therapy
  • Juno Therapeutics Inc.
  • CHIMERIC ANTIGEN RECEPTOR-T CELL THERAPY

CLINICAL TRIAL RESULTS FOR CD## CAR, KTE-C## CAR, EGFRVIII CAR, NY-ESO-## TCR AND MAGE A##/ A## TCR HAVE BEEN DISCUSSED EARLIER IN CHAPTER ## AND ##.

  • Automotive
  • Cell Therapy
  • Motor Vehicle
  • Therapy
  • Juno Therapeutics Inc.